Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer

OBJECTIVE: Glucose transporter-1 is a marker involved in energy transport in cancer cells. It has been shown to be a poor prognostic factor in many cancer types, including breast cancer. However, there is no satisfactory parameter predicting treatment in breast cancer patients receiving neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Öztürk, Seda Duman, Öztürk, Çiğdem, Okcu, Oğuzhan, Aşkan, Gökçe, Şen, Bayram, Bedir, Recep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004294/
https://www.ncbi.nlm.nih.gov/pubmed/36921199
http://dx.doi.org/10.1590/1806-9282.20221334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004294/
https://www.ncbi.nlm.nih.gov/pubmed/36921199
http://dx.doi.org/10.1590/1806-9282.20221334

Ejemplares similares